Ahles, T. A., & Root, J. C. (2018). Cognitive effects of cancer and cancer treatments. Annu Rev Clin Psychol,14, 425–451. https://doi.org/10.1146/annurev-clinpsy-050817-084903

Article  PubMed  PubMed Central  Google Scholar 

Ahles, T. A., Root, J. C., & Ryan, E. L. (2012). Cancer- and cancer treatment-associated cognitive change: An update on the state of the science. Journal Of Clinical Oncology,30(30), 3675–3686. https://doi.org/10.1200/jco.2012.43.0116

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. Journal Of Clinical Oncology, 28(29), 4434–4440. https://doi.org/10.1200/jco.2009.27.0827

Amidi, A., Agerbæk, M., Wu, L. M., Pedersen, A. D., Mehlsen, M., Clausen, C. R., Demontis, D., Børglum, A. D., Harbøll, A., & Zachariae, R. (2017). Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment. Brain Imaging and Behavior, 11(3), 769–783. https://doi.org/10.1007/s11682-016-9552-3

Amidi, A., & Wu, L. M. (2019). Structural brain alterations following adult non-CNS cancers: A systematic review of the neuroimaging literature. Acta Oncologica,58(5), 522–536. https://doi.org/10.1080/0284186x.2018.1563716

Article  CAS  PubMed  Google Scholar 

Apple, A. C., Ryals, A. J., Alpert, K. I., Wagner, L. I., Shih, P. A., Dokucu, M., & Wang, L. (2017). Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns. NeuroImage: Clinical,14, 685–691. https://doi.org/10.1016/j.nicl.2017.03.004

Article  PubMed  Google Scholar 

Ashburner, J., & Friston, K. J. (2000). Voxel-based morphometry–the methods. Neuroimage,11(6 Pt 1), 805–821. https://doi.org/10.1006/nimg.2000.0582

Article  CAS  PubMed  Google Scholar 

Ashburner, J., & Friston, K. J. (2001). Why voxel-based morphometry should be used. Neuroimage,14(6), 1238–1243. https://doi.org/10.1006/nimg.2001.0961

Article  CAS  PubMed  Google Scholar 

Ashburner, J., Hutton, C., Frackowiak, R., Johnsrude, I., Price, C., & Friston, K. (1998). Identifying global anatomical differences: Deformation-based morphometry. Human Brain Mapping,6(5–6), 348–357. https://doi.org/10.1002/(SICI)1097-0193(1998)6:5/6%3c348::AID-HBM4%3e3.0.CO;2-P

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergouignan, L., Lefranc, J. P., Chupin, M., Morel, N., Spano, J. P., & Fossati, P. (2011). Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval. PLoS One,6(10), e25349. https://doi.org/10.1371/journal.pone.0025349

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blommaert, J., Schroyen, G., Vandenbulcke, M., Radwan, A., Smeets, A., Peeters, R., Sleurs, C., Neven, P., Wildiers, H., Amant, F., Sunaert, S., & Deprez, S. (2019). Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients. Human Brain Mapping, 40(17), 4994–5010. https://doi.org/10.1002/hbm.24753

Boyle, R., Jollans, L., Rueda-Delgado, L. M., Rizzo, R., Yener, G. G., McMorrow, J. P., Knight, S. P., Carey, D., Robertson, I. H., Emek-Savaş, D. D., Stern, Y., Kenny, R. A., & Whelan, R. (2021). Brain-predicted age difference score is related to specific cognitive functions: A multi-site replication analysis. Brain Imaging and Behavior, 15(1), 327–345. https://doi.org/10.1007/s11682-020-00260-3

Carroll, J. E., Van Dyk, K., Bower, J. E., Scuric, Z., Petersen, L., Schiestl, R., & Ganz, P. A. (2019). Cognitive performance in survivors of breast cancer and markers of biological aging. Cancer,125(2), 298–306. https://doi.org/10.1002/cncr.31777

Article  CAS  PubMed  Google Scholar 

Chen, B. T., Jin, T., Patel, S. K., Ye, N., Sun, C. L., Ma, H., Rockne, R. C., Root, J. C., Saykin, A. J., Ahles, T. A., Holodny, A. I., Prakash, N., …, & Hurria, A. (2018). Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer. Breast Cancer Research And Treatment, 172(2), 363–370. https://doi.org/10.1007/s10549-018-4911-y

Cole, J. H. (2018). Neuroimaging studies illustrate the commonalities between ageing and brain diseases. Bioessays,40(7), e1700221. https://doi.org/10.1002/bies.201700221

Article  PubMed  Google Scholar 

Cole, J. H. (2020). Multimodality neuroimaging brain-age in UK biobank: Relationship to biomedical, lifestyle, and cognitive factors. Neurobiology Of Aging,92, 34–42. https://doi.org/10.1016/j.neurobiolaging.2020.03.014

Article  PubMed  PubMed Central  Google Scholar 

Cole, J. H., & Franke, K. (2017). Predicting age using neuroimaging: Innovative brain ageing biomarkers. Trends In Neurosciences,40(12), 681–690. https://doi.org/10.1016/j.tins.2017.10.001

Article  CAS  PubMed  Google Scholar 

Cole, J. H., Underwood, J., Caan, M. W., De Francesco, D., van Zoest, R. A., Leech, R., & Sharp, D. J. (2017). Increased brain-predicted aging in treated HIV disease. Neurology,88(14), 1349–1357. https://doi.org/10.1212/wnl.0000000000003790

Article  PubMed  PubMed Central  Google Scholar 

Conroy, S. K., McDonald, B. C., Smith, D. J., Moser, L. R., West, J. D., Kamendulis, L. M., Klaunig, J. E., Champion, V. L., Unverzagt, F. W., & Saykin, A. J. (2013). Alterations in brain structure and function in breast cancer survivors: Effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Research And Treatment, 137(2), 493–502. https://doi.org/10.1007/s10549-012-2385-x

Correa, D. D., Root, J. C., Baser, R., Moore, D., Peck, K. K., Lis, E., Shore, T. B., Thaler, H. T., Jakubowski, A., & Relkin, N. (2013). A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain Imaging Behav, 7(4), 478–490. https://doi.org/10.1007/s11682-013-9221-8

Correa, D. D., Root, J. C., Kryza-Lacombe, M., Mehta, M., Karimi, S., Hensley, M. L., & Relkin, N. (2017). Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: A pilot study. Brain Imaging Behav,11(6), 1652–1663. https://doi.org/10.1007/s11682-016-9608-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., Lavini, C., Linn, S. C., Boven, E., van Dam, F. S. A. M., & Schagen, S. B. (2012). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Human Brain Mapping, 33(12), 2971–2983. https://doi.org/10.1002/hbm.21422

Franke, K., & Gaser, C. (2019). Ten years of BrainAGE as a neuroimaging biomarker of brain aging: What insights have we gained? Frontiers In Neurology,10, 789. https://doi.org/10.3389/fneur.2019.00789

Article  PubMed  PubMed Central  Google Scholar 

Franke, K., Gaser, C., Manor, B., & Novak, V. (2013). Advanced BrainAGE in older adults with type 2 diabetes mellitus. Frontiers In Aging Neuroscience,5, 90. https://doi.org/10.3389/fnagi.2013.00090

Article  PubMed  PubMed Central  Google Scholar 

Gaser, C., Franke, K., Klöppel, S., Koutsouleris, N., & Sauer, H. (2013). BrainAGE in mild cognitive impaired patients: Predicting the conversion to Alzheimer’s disease. PLoS One,8(6), e67346. https://doi.org/10.1371/journal.pone.0067346

Article  CAS  PubMed  PubMed Central  Google Scholar 

Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N., Friston, K. J., & Frackowiak, R. S. (2001). A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage,14(1 Pt 1), 21–36. https://doi.org/10.1006/nimg.2001.0786

Article  CAS  PubMed  Google Scholar 

Guida, J. L., Ahles, T. A., Belsky, D., Campisi, J., Cohen, H. J., DeGregori, J., Fuldner, R., Ferrucci, L., Gallicchio, L., Gavrilov, L., Gavrilova, N., Green, P. A., …, & Hurria, A. (2019). Measuring aging and identifying aging phenotypes in cancer survivors. Journal of the National Cancer Institute, 111(12), 1245–1254. https://doi.org/10.1093/jnci/djz136

Henneghan, A., Rao, V., Harrison, R. A., Karuturi, M., Blayney, D. W., Palesh, O., & Kesler, S. R. (2020). Cortical brain age from pre-treatment to post-chemotherapy in patients with breast cancer. Neurotoxicity Research,37(4), 788–799. https://doi.org/10.1007/s12640-019-00158-z

Article  PubMed  PubMed Central  Google Scholar 

Hosseini, S. M., Koovakkattu, D., & Kesler, S. R. (2012). Altered small-world properties of gray matter networks in breast cancer. Bmc Neurology,12, 28. https://doi.org/10.1186/1471-2377-12-28

Article  PubMed  PubMed Central  Google Scholar 

Hurria, A., Jones, L., & Muss, H. B. (2016). Cancer treatment as an accelerated aging process: Assessment, biomarkers, and interventions. American Society of Clinical Oncology Education Book,35, e516-522. https://doi.org/10.1200/edbk_156160

Article  Google Scholar 

Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., Wada, N., Imoto, S., Murakami, K., & Uchitomi, Y. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109(1), 146–156. https://doi.org/10.1002/cncr.22368

Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014). Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry,26(1), 102–113. https://doi.org/10.3109/09540261.2013.864260

Article  PubMed  PubMed Central  Google Scholar 

Jenkins, V., Thwaites, R., Cercignani, M., Sacre, S., Harrison, N., Whiteley-Jones, H., Mullen, L., Chamberlain, G., Davies, K., Zammit, C., Matthews, L., & Harder, H. (2016). A feasibility study exploring the role of pre-operative assessment when examining the mechanism of ‘chemo-brain’ in breast cancer patients. Springerplus, 5, 390. https://doi.org/10.1186/s40064-016-2030-y

Kaiser, J., Bledowski, C., & Dietrich, J. (2014). Neural correlates of chemotherapy-related cognitive impairment. Cortex; A Journal Devoted to the Study of the Nervous System and Behavior,54, 33–50. https://doi.org/10.1016/j.cortex.2014.01.010

Article  PubMed  Google Scholar 

Kesler, S., Janelsins, M., Koovakkattu, D., Palesh, O., Mustian, K., Morrow, G., & Dhabhar, F. S. (2013). Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain, Behavaior, and Immunity,30 Suppl(0), S109-116. https://doi.org/10.1016/j.bbi.2012.05.017

Article  CAS  Google Scholar 

Koppelmans, V., de Ruiter, M. B., van der Lijn, F., Boogerd, W., Seynaeve, C., van der Lugt, A., Vrooman, H., Niessen, W. J., Breteler, M. M. B., & Schagen, S. B. (2012). Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Research and Treatment, 132(3), 1099–1106. https://doi.org/10.1007/s10549-011-1888-1

Lange, M., Heutte, N., Noal, S., Rigal, O., Kurtz, J. E., Lévy, C., Allouache, D., Rieux, C., Lefel, J., Clarisse, B., Leconte, A., Veyret, C., …, & Joly, F. (2019). Cognitive changes after adjuvant treatment in older adults with early-stage breast cancer. The Oncologist, 24(1), 62–68. https://doi.org/10.1634/theoncologist.2017-0570

Lange, M., Joly, F., Vardy, J., Ahles, T., Dubois, M., Tron, L., Winocur, G., de Ruiter, M. B., & Castel, H. (2019). Cancer-related cognitive impairment: An update on state of the art, detection, and management strategies in cancer survivors. Annals of Oncology, 30(12), 1925–1940. https://doi.org/10.1093/annonc/mdz410

Lepage, C., Smith, A. M., Moreau, J., Barlow-Krelina, E., Wallis, N., Collins, B., MacKenzie, J., & Scherling, C. (2014). A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients. Springerplus, 3, 444. https://doi.org/10.1186/2193-1801-3-444

Li, M., & Caeyenberghs, K. (2018). Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review. Neuroscience and Biobehavioral Reviews,92, 304–317. https://doi.org/10.1016/j.neubiorev.2018.05.019

Article  PubMed  Google Scholar 

McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study. Breast Cancer Research and Treatment,123(3), 819–828. https://doi.org/10.1007/s10549-010-1088-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

McDonald, B. C., Conroy, S. K., Smith, D. J., West, J. D., & Saykin, A. J. (2013). Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain, Behavior, and Immunity,30 Suppl(0), S117-125. https://doi.org/10.1016/j.bbi.2012.05.007

Article  PubMed  Google Scholar 

McDonald, B. C., & Saykin, A. J. (2013). Alterations in brain structure related to breast cancer and its treatment: Chemotherapy and other considerations. Brain Imaging Behav,7(4), 374–387. https://doi.org/10.1007/s11682-013-9256-x

Article  PubMed  Google Scholar 

Mentzelopoulos, A., Gkiatis, K., Karanasiou, I., Karavasilis, E., Papathanasiou, M., Efstathopoulos, E., Kelekis, N., Kouloulias, V., & Matsopoulos, G. K. (2021). Chemotherapy-induced brain effects in small-cell lung cancer patients: A multimodal MRI study. Brain Topography, 34(2), 167–181. https://doi.org/10.1007/s10548-020-00811-3

Niu, R., Du, M., Ren, J., Qing, H., Wang, X., Xu, G., Lei, D., & Zhou, P. (2021). Chemotherapy-induced grey matter abnormalities in cancer survivors: A voxel-wise neuroimaging meta-analysis. Brain Imaging and Behavior, 15(4), 2215–2227. https://doi.org/10.1007/s11682-020-00402-7

Schilder, C. M., Seynaeve, C., Beex, L. V., Boogerd, W., Linn, S. C., Gundy, C. M., Huizenga, H. M., Nortier, J. W., van de Velde, C. J., van Dam, F. S., & Schagen, S. B. (2010). Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: Results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. Journal of Clinical Oncology, 28(8), 1294–1300. https://doi.org/10.1200/jco.2008.21.3553

Schwarz, D., & Kašpárek, T. (2011). Comparison of two methods for automatic brain morphometry analysis. Radioengineering,20(4), 996–1001.